Former FDA Chief Comments on the Drug Approval Process

In this Medscape One-on-One video, former FDA Commissioner and former director of the National Cancer Institute Andrew von Eschenbach, MD, suggests using adaptive trial design to test drugs rather than a stepwise approach.

Dr. Eschenbach notes that every patient wants personalized medicine--and we now have the tools to be more precise in that endeavor.

Watch the video here.